[Information provided by:
ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]
|NCT02367469 : Tryptophan Metabolism in Human Brain Tumors|
|Ages||Min: 13 Years Max: N/A|
1. Clinical and MRI diagnosis of an intracranial lesion suspicious for a brain tumor,
including primary and metastatic tumors, or a possible residual or recurrent brain
tumor (based on clinical imaging); or history of glioma treatment with chemoradiation,
even if no definite progression is found on clinical MRI.
2. Age =13 years.
1. Severe increased intracranial pressure, status epilepticus, or other symptoms
requiring emergency or urgent intervention.
2. Resective surgery within 2 months prior to the PET scan (acute/subacute post-surgical
inflammatory changes may cause false positive increases on AMT PET).
3. Positive pregnancy test (because of radiation involved in PET scanning).
|Links||Permanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02367469
| Link to official Clinicaltrials.gov listing